Policy and Advocacy Shorts with Diane Berry, PhD

Diane Berry, PhD, Executive Vice President, Chief Global Policy & Advocacy Officer at Sarepta Therapeutics, highlights ASGCT's unique role in bringing together diverse stakeholders and providing evidence-based advocacy to advance policies in cell and gene therapy.